Drug Pipeline

Pravastatin 20 mg oral tablet (ages <13 years), or 40 mg oral tablet (≥14 years) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
5
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 2
4
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06912763 Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional… Fibrosis Syndrome Recruiting
NCT06494111 Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol… Lymphedema Recruiting
NCT07098975 Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial) Preeclampsia (PE) Recruiting
NCT07217938 Novel Treatment of Radiation Associated Dysphagia With Statins Radiation-associated Dysphagia Recruiting
Phase 1
NCT06324396 IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated… Fontan Circulation Recruiting
Sponsors Running Pravastatin 20 mg oral tablet (ages <13 years), or 40 mg oral tablet (≥14 years) Trials
M.D. Anderson Cancer Center (2) Children's Mercy Hospital Kansas City (1) Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) Peter MacCallum Cancer Centre, Australia (1)
Get alerts when Pravastatin 20 mg oral tablet (ages <13 years), or 40 mg oral tablet (≥14 years) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free